telaprevir
Term · Oncology and biomedicine · MLC-T-ONC-017046
An orally available peptidomimetic small molecule with activity against hepatitis C virus (HCV). Telaprivir is a selective protease inhibitor that targets the viral HCV NS3-4A serine protease and disrupts processing of viral proteins and formation of a viral replication complex.
| Identifier | MLC-T-ONC-017046 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017046",
"term": "telaprevir",
"field": "Oncology and biomedicine",
"definition": "An orally available peptidomimetic small molecule with activity against hepatitis C virus (HCV). Telaprivir is a selective protease inhibitor that targets the viral HCV NS3-4A serine protease and disrupts processing of viral proteins and formation of a viral replication complex.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/telaprevir/"
}
Record 16,113 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.